Microsurgical treatment of patients with refractory epilepsy and mesial temporal cavernous malformations: clinical experience of a tertiary epilepsy center

dc.creatorMeguins, Lucas Crociati
dc.creatorAdry, Rodrigo Antonio Rocha da Cruz
dc.creatorSilva Junior, Sebastião Carlos da
dc.creatorPereira, Carlos Umberto
dc.creatorOliveira, Jean Goncalves de
dc.creatorMorais, Dionei Freitas de
dc.creatorAraujo Filho, Gerardo Maria de
dc.creatorMarques, Lúcia Helena Neves
dc.date2017-02-23T20:38:57Z
dc.date2017-02-23T20:38:57Z
dc.date2015-11
dc.date.accessioned2023-09-28T22:46:17Z
dc.date.available2023-09-28T22:46:17Z
dc.identifierMEGUINS, L. C. et al. Microsurgical treatment of patients with refractory epilepsy and mesial temporal cavernous malformations: clinical experience of a tertiary epilepsy center. Surgical Neurology International, v. 6, nov. 2015. Disponível em: <http://surgicalneurologyint.com/surgicalint_articles/microsurgical-treatment-of-patients-with-refractory-epilepsy-and-mesial-temporal-cavernous-malformations-clinical-experience-of-a-tertiary-epilepsy-center/>. Acesso em: 23 fev. 2017.
dc.identifier2152-7806
dc.identifierhttps://ri.ufs.br/handle/riufs/1972
dc.identifierCreative Commons Attribution-NonCommercial-ShareAlike 3.0 License
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9077526
dc.descriptionBackground: Mesiotemporal cavernous malformation can occur in 10–20% of patients with cerebral cavernomas and are frequently associated with refractory. Methods: A retrospective investigation was performed in the epilepsy clinic of a Brazilian tertiary referral epilepsy center, from January 2000 to March 2012. Results: A total of 21 patients were included in the study. Thirteen patients (62%) evolved to Engel I; 5 (24%) to Engel II, 2 (10%) to Engel III, and 1 (5%) to Engel IV. We observed that 10 (48%) patients with 12 years or less of epilepsy duration evolved to Engel I and 1 (5%) to Engel II; whereas from a total of 10 patients with epilepsy duration of more than 12 years, 3 (30%) evolved to Engel I and 7 (70%) to Engel II, III, or IV (P < 0.001 [bilateral]; P1 ≠ P2). Conclusion: Postsurgical seizure outcome for temporal lobe epilepsy associated with mesiotemporal cavernomas is very satisfactory.
dc.formatapplication/pdf
dc.languageen
dc.publisherWolters Kluwer - Medknow
dc.subjectCavernous malformations
dc.subjectMesiotemporal cavernous malformation
dc.subjectTemporal lobe epilepsy
dc.subjectEpilepsia do lobo temporal
dc.titleMicrosurgical treatment of patients with refractory epilepsy and mesial temporal cavernous malformations: clinical experience of a tertiary epilepsy center
dc.typeArtigo


Este ítem pertenece a la siguiente institución